Does the polymorphism 677C-T of the 5,10-methylenetetrahydrofolate reductase gene contribute to homocysteine-related vascular disease?

Journal of Inherited Metabolic Disease

Volumn 21, Issue 8, 1998, Pages 812-822

  Thuillier, L ^a   Chadefaux Vekemans, B ^a   Bonnefont, J P ^a   Kara, A ^a   Aupetit, J ^a   Rochette, C ^a   Montalescot, G ^b   Couty, M C ^b   Kamoun, P ^a   Ankri, A ^b  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); FOLIC ACID; HOMOCYSTEINE;

ADULT; AGED; AMINO ACID BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; FEMALE; FRANCE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HOMOCYSTINURIA; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; RISK FACTOR; VASCULAR DISEASE;

5,10-METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ERYTHROCYTES; FEMALE; FOLIC ACID; GENOTYPE; HOMOCYSTEINE; HUMANS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; OXIDOREDUCTASES; POLYMORPHISM, GENETIC; RISK FACTORS; VASCULAR DISEASES; VITAMIN B 12;

EID: 7844236391     PISSN: 01418955     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005414617390     Document Type: Article

References (33)

1. Arruda VR, Von Zuben PM, Chiaparini LC, Annichino-Bizzacchi JM, Costa FF (1997) The mutation Ala-677-Val in the methylenetetrahydrofolate reductase gene: a risk factor for arterial disease and venous thrombosis. Thromb Haemost 77: 818-821.
2. Boers GHJ, Smals AGH, Trijbels JMF et al (1985) Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease. N Engl J Med 313: 709-715.
3. Bonham JR, Moat SJ, Guthrie PAI et al (1996) The thermolabile methylenetetrahydrofolate reductase (MTHFR) mutation - a common finding in the UK population. J Inher Metab Dis 19 (Supplement 1): 23.
4. Brugada R, Marian AJ (1997) A common mutation in methylenetetrahydrofolate reductase gene is not a major risk of coronary artery disease or myocardial infarction. Atherosclerosis 128: 107-112.
5. Chadefaux B, Coudé M, Hamet M, Aupetit J, Kamoun P (1989) Rapid determination of total homocysteine in plasma. Clin Chem 35: 2002.
6. Clarke R, Daly L, Robinson K et al (1991) Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med 324: 1149-1155.
7. Cordoba A, Cirera S, Carrascosa C et al (1996) The thermolabile methylenetetrahydrofolate reductase (MTHFR) and hyperhomocysteinemia in patients with nonhaemorrhagic cerebro-vascular disease. J Inher Metab Dis 19 (Supplement 1): 23.
8. De Franchis R, Mancini F, D'Angelo A et al (1996) Elevated total plasma homocysteine and 677C-T mutation of the 5,10-methylenetetrahydrofolate reductase gene in thrombotic vascular disease. Am J Hum Genet 59: 262-264.
9. Delougherty TG, Evans A, Sadeghi A et al (1996) Common mutation in methylenetetrahydrofolate reductase - correlation with homocysteine metabolism and late-onset vascular disease. Circulation 94: 3074-3078.
10. Den Heijer M, Blom HJ, Gerrits WBJ et al (1995) Is hyperhomocysteinemia a risk factor for recurrent venous thrombosis? J Inher Metab Dis 19 (Supplement 1): 23.
11. Engbersen AMT, Franken DG, Boers GHJ, Stevens EMB, Trijbels JMF, Blom HJ (1995) Thermolabile 5,10-methylenetetrahydrofolate reductase as a cause of mild hyperhomocysteinemia. Am J Hum Genet 56: 142-150.
12. Franken DG, Boers GHJ, Blom HJ, Trijbels FJM, Kloppenborg PWC (1994) Treatment of mild hyperhomocysteinemia in vascular disease patients. Arterioscler Thromb 14: 465-470.
13. Frosst P, Blom HJ, Milos R et al (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nature Genetics 10: 111-113.
14. Genest J Jr (1990) Plasma homocysteine levels in men with premature coronary artery disease. J Am Coll Cardiol 16: 1114-1119.
15. Goyette P, Sumner JS, Milos R et al (1994) Human methylenetetrahydrofolate reductase: isolation of cDNA, mapping and mutation identification. Nature Genetics 7: 195-200.
16. Gulati S, Baker P, Li YN et al (1996) Defects in human methionine synthase in cb1G patients. Hum Mol Genet 5: 1859-1865.
17. Izumi M, Iwai N, Ohmichi N, Nakamura Y, Shimoike H, Kinoshita M (1996) Molecular variant of 5,10-methylenetetrahydrofolate reductase is a risk factor of ischemic heart disease in the Japanese population. Atherosclerosis 121: 293-294.
18. Jacques PF, Bostom AG, Williams RR et al (1996) Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 93: 7-9.
19. Kang S-S, Wong PWK, Susmano A, Sora J, Norusis M, Ruggie N (1991) Thermolabile methylenetetrahydrofolate reductase in coronary artery disease. Am J Hum Genet 48: 536-545.
20. Kang S-S, Passen EL, Ruggie N, Wong PWK, Sora H (1993) Thermolabile defect of methylenetetrahydrofolate reductase in coronary artery disease. Circulation 88 (pt1): 1463-1469.
21. Kluijtmans LAJ, Van Den Heuvel LPWJ, Boers GHJ et al (1996) Molecular genetic analysis in mild hyperhomocysteinemia: a common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease. Am J Hum Genet 58: 35-41.
22. Marquet J, Chadefaux B, Bonnefont JP, Saudubray JM, Zittoun J (1994) Methylenetetrahydrofolate reductase deficiency: prenatal diagnosis and family studies. Prenat Diagn 14: 29-33.
23. Morita H, Tagushi J, Kurihara H et al (1997) Genetic polymorphism of 5,10-methylenetetrahydrofolate reductase (MTHFR) as a risk factor for coronary artery disease. Circulation 95: 2032-2036.
24. Motulsky A (1996) Nutritional ecogenetics: homocysteine-related arteriosclerotic vascular disease, neural tube defects, and folic acid. Am J Hum Genet 58: 17-20.
25. Priest DE (1986) Folates in tissues and cells. In Copper BA Whitehead VM, eds. Chemistry and Biology of Pteridines. Pteridines and Folic Acid Derivatives. Berlin: de Gruyter, 479-487.
26. Rees DC, Liu YT, Cox MJ, Elliott P, Wainscoat JS (1997) Factor V Leiden and thermolabile methylenetetrahydrofolate reductase in extreme old age. Thromb Haemost 78: 1357-1359.
27. Refsum H, Velland PM (1985) Radioenzymatic determination of homocysteine in plasma and urine. Clin Chem 31: 624-628.
28. Selhub J, Jacques PF, Bostom AG et al (1995) Association between plasma homocysteine concentrations and extracranial carotid artery stenosis. N Engl J Med 332: 286-291.
29. Stampfer MJ, Malinow MR (1995) Can lowering homocysteine levels reduce cardiovascular risk? N Engl J Med 332: 328-329.
30. Stampfer MJ, Malinow MR, Willet WC et al (1992) A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. J Am Med Assoc 268: 877-881.
31. Vanbockxmeer FM, Mamotte CDS, Vasikaran SD, Taylor RR (1997) Methylenetetrahydrofolate reductase gene and coronary artery disease. Circulation 95: 21-23.
32. Visy JM, Le Coz P, Chadefaux B et al (1991) Homocysteinuria due to 5,10-methylene tetrahydrofolate reductase deficiency revealed by stroke in adult siblings. Neurology 41: 1313-1315.
33. Whitehead AS, Gallagher P, Mills JL et al (1995) A genetic defect in 5,10-methylenetetrahydrofolate reductase in neural tube defect. Q J Med 88: 763-766.